Hypertension, Resistant to Conventional Therapy Clinical Trial
Official title:
Renal Denervation in Patients With Resistant Hypertension
The DENER-HTN study is a, multicenter, prospective, open, randomized, controlled study of the effectiveness and costs of renal denervation in addition to standardized medical treatment compared to medical treatment alone in subjects with resistant hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF) energy through the luminal surface of the renal artery.
The DENER-HTN study is a, multicenter, prospective, open, randomized, controlled study of the efficacy and cost-effectiveness of renal denervation plus standardized optimal antihypertensive treatment compared to standardized optimal antihypertensive treatment alone in patients with proven resistant hypertension. Patients with essential resistant hypertension will first enter a 4-week run-in period during which they will receive a standardized triple combination therapy (diuretic+ ACE inhibitor+ CCB at maximal dose). After 4 weeks of standardized triple therapy patients will be randomized to renal denervation + optimal antihypertensive treatment compared to standardized optimal antihypertensive treatment if daytime ambulatory BP remains ≥ 135 and/or 85 mmHg. Bilateral renal denervation will be performed using the Symplicity Catheter (Medtronic ®) - a percutaneous system that delivers radiofrequency (RF) energy through the luminal surface of the renal artery. Study amendment: Extended follow-up of 48 months for all randomized patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02385864 -
CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension
|
N/A | |
| Completed |
NCT01833429 -
Autonomic Dysfunction in Resistant Hypertension
|
N/A | |
| Completed |
NCT02426099 -
Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension
|
Phase 4 | |
| Recruiting |
NCT02623036 -
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
|
Phase 1 | |
| Completed |
NCT02587533 -
Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation
|
N/A | |
| Recruiting |
NCT01863082 -
Resistant Hypertension and Physical Activity Performed in a Heated Pool
|
N/A | |
| Terminated |
NCT03730519 -
UK Registry for Baroreflex Activation Therapy
|
N/A | |
| Active, not recruiting |
NCT05017935 -
RADIANCE Continued Access Protocol
|
N/A | |
| Completed |
NCT01520506 -
Rapid Renal Sympathetic Denervation for Resistant Hypertension
|
N/A | |
| Active, not recruiting |
NCT02369081 -
Optimum Treatment for Drug-Resistant Hypertension
|
Phase 4 | |
| Withdrawn |
NCT04542681 -
MANP in African Americans With Hypertension
|
Phase 1 | |
| Completed |
NCT05395403 -
Use of Automated Office Blood Pressure Monitoring
|
N/A | |
| Recruiting |
NCT02057783 -
Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
|
N/A | |
| Completed |
NCT01630928 -
Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors
|
N/A | |
| Completed |
NCT01848275 -
Full Length Versus Proximal Renal Arteries Ablation
|
N/A | |
| Completed |
NCT01062763 -
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
|
Phase 3 | |
| Completed |
NCT01834118 -
Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
|
N/A | |
| Active, not recruiting |
NCT01703780 -
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
|
N/A | |
| Not yet recruiting |
NCT02042066 -
Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension
|
Phase 1 | |
| Completed |
NCT02667912 -
Distal Renal Denervation
|
N/A |